Literature DB >> 3813948

Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage.

J T Thompson, S de Bustros, R G Michels, T A Rice.   

Abstract

The final visual acuities and prognostic factors predictive of these results were analyzed in 353 eyes that had pars plana vitrectomy for nonclearing diabetic vitreous hemorrhage. Eighty-one percent of the eyes had improved visual acuities on final examination. The percentage of eyes that achieved a visual acuity of 20/100 or better and the percentage that achieved 5/200 or better increased during the study period. Preoperative factors associated with a favorable visual prognosis included the following: preoperative visual acuity of 5/200 or better, absence of iris neovascularization, absence of neovascular glaucoma, clear lens or minimal cataract, and panretinal photocoagulation of at least one fourth of the fundus. Intraoperative factors associated with a favorable visual prognosis included retaining the crystalline lens and absence of an intraocular gas bubble.

Entities:  

Mesh:

Year:  1987        PMID: 3813948     DOI: 10.1001/archopht.1987.01060020045025

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

2.  Posterior chamber intraocular lens implantation during pars plana lensectomy and vitrectomy for diabetic complications.

Authors:  G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 3.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

4.  Thrombolysis in patients with diabetes. More evidence that the treatment should not necessarily be withheld.

Authors:  D K Newman; M P Snead; D W Flanagan; J D Scott
Journal:  BMJ       Date:  1995-04-15

5.  Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.

Authors:  J K French; B F Williams; H H Hart; S Wyatt; J E Poole; C Ingram; C J Ellis; M G Williams; H D White
Journal:  BMJ       Date:  1996-06-29

6.  Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.

Authors:  Yongeun Lee; Seungbum Kang; Young-Hoon Park
Journal:  Korean J Ophthalmol       Date:  2013-01-09

7.  The Outcomes of Pars Plana Vitrectomy without Tamponade for Tractional Retinal Detachment Secondary to Diabetic Retinopathy.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Malays J Med Sci       Date:  2013-05

8.  Significance of various systemic and ocular parameters in the long-term prognosis after diabetic vitrectomy.

Authors:  P Summanen
Journal:  Int Ophthalmol       Date:  1989-09       Impact factor: 2.031

9.  Sulfur Hexafluoride 20% versus Lactated Ringer's Solution for Prevention of Early Postoperative Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Fereydoun Farrahi; Mostafa Feghhi; Biuk Bagherzadeh; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2010-04

10.  Transition to a novel advanced integrated vitrectomy platform: comparison of the surgical impact of moving from the Accurus vitrectomy platform to the Constellation Vision System for microincisional vitrectomy surgery.

Authors:  Timothy G Murray; Andrew J Layton; Kuo B Tong; Michael Gittelman; Azeema Latiff; Daniel Gologorsky; Michael M Vigoda
Journal:  Clin Ophthalmol       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.